198 related articles for article (PubMed ID: 37470509)
21. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
Mohanka M; Khemasuwan D; Stoller JK
Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
[TBL] [Abstract][Full Text] [Related]
22. Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.
Wozniak J; Wandtke T; Kopinski P; Chorostowska-Wynimko J
Hum Gene Ther; 2015 Nov; 26(11):709-18. PubMed ID: 26413996
[TBL] [Abstract][Full Text] [Related]
23. Introducing standards of the best medical practice for patients with inherited alpha-1-antitrypsin deficiency in Central Eastern Europe.
Valiulis A; Utkus A; Stukas R; Valiulis A; Siderius L;
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):107-14. PubMed ID: 24798601
[TBL] [Abstract][Full Text] [Related]
24. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.
Padilla-Godínez FJ; Ramos-Acevedo R; Martínez-Becerril HA; Bernal-Conde LD; Garrido-Figueroa JF; Hiriart M; Hernández-López A; Argüero-Sánchez R; Callea F; Guerra-Crespo M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830348
[TBL] [Abstract][Full Text] [Related]
25. Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?
Crossley D; Stockley R; Sapey E
Drugs Aging; 2019 Sep; 36(9):823-840. PubMed ID: 31179525
[TBL] [Abstract][Full Text] [Related]
26. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
27. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
Turner AM
BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
[TBL] [Abstract][Full Text] [Related]
28. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
29. In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency.
Song CQ; Wang D; Jiang T; O'Connor K; Tang Q; Cai L; Li X; Weng Z; Yin H; Gao G; Mueller C; Flotte TR; Xue W
Hum Gene Ther; 2018 Aug; 29(8):853-860. PubMed ID: 29597895
[TBL] [Abstract][Full Text] [Related]
30. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
[TBL] [Abstract][Full Text] [Related]
31. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
32. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
33. The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocellular and murine models.
Lu Y; Wang LR; Lee J; Mohammad NS; Aranyos AM; Gould C; Khodayari N; Oshins RA; Moneypenny CG; Brantly ML
Hepatol Commun; 2022 Sep; 6(9):2354-2367. PubMed ID: 35621045
[TBL] [Abstract][Full Text] [Related]
34. Testing Alpha-1 Antitrypsin Deficiency in Black Populations.
Lafortune P; Zahid K; Ploszaj M; Awadalla E; Carroll TP; Geraghty P
Adv Respir Med; 2023 Dec; 92(1):1-12. PubMed ID: 38392031
[TBL] [Abstract][Full Text] [Related]
35. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
[TBL] [Abstract][Full Text] [Related]
36. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
37. The Recruitment-Secretory Block ("R-SB") Phenomenon and Endoplasmic Reticulum Storage Diseases.
Callea F; Tomà P; Bellacchio E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202771
[TBL] [Abstract][Full Text] [Related]
38. Characterization of hepatic inflammatory changes in a C57BL/6J mouse model of alpha1-antitrypsin deficiency.
Khodayari N; Oshins R; Aranyos AM; Duarte S; Mostofizadeh S; Lu Y; Brantly M
Am J Physiol Gastrointest Liver Physiol; 2022 Dec; 323(6):G594-G608. PubMed ID: 36256438
[TBL] [Abstract][Full Text] [Related]
39. A perspective on RNA interference-based therapeutics for metabolic liver diseases.
Alkhouri N; Gawrieh S
Expert Opin Investig Drugs; 2021 Mar; 30(3):237-244. PubMed ID: 33470860
[No Abstract] [Full Text] [Related]
40. Alpha-1-antitrypsin deficiency.
Bals R
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
